XML 47 R35.htm IDEA: XBRL DOCUMENT
v3.23.2

CRISPR Collaboration Agreement - Additional Information (Details) - Research Collaboration Agreement |  | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
May 05, 2021 CrisprCas9 | Jun. 30, 2023 USD ($) | Jun. 30, 2022 USD ($) | Jun. 30, 2023 USD ($) | Jun. 30, 2022 USD ($)
Development and Regulatory Approval Milestones |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |
Reduction of research and development expense resulting from partial reimbursement |  | $ 300,000 | $ 700,000 | $ 1,200,000 | $ 1,800,000
Receivable under research cost sharing provision |  | $ 1,200,000 |  | $ 1,200,000 |
Potential future payments |  |  |  | totaling less than mid-twenty million dollars |
Amount paid under the agreement |  |  |  | $ 0 |
Amounts owed under the agreement |  |  |  | $ 0 |
NK Cell Products |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |
Number of non-exclusive rights to gene editing targets licenses received | CrisprCas9 | 4 |  |  |  |
NK Cell Products | Minimum |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |
Number of non-exclusive rights to gene editing targets | CrisprCas9 | 1 |  |  |  |
Specified TA | Development and Regulatory Approval Milestones |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |
Potential future payments |  |  |  | totaling less than high-forty million dollars |

X
- Definition Amounts owed under agreement. + References No definition available. + Details
Name: | nktx_AmountsOwedUnderAgreement
Namespace Prefix: | nktx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of non exclusive rights to gene editing targets. + References No definition available. + Details
Name: | nktx_NumberOfNonExclusiveRightsToGeneEditingTargets
Namespace Prefix: | nktx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of non exclusive rights to gene editing targets licenses received. + References No definition available. + Details
Name: | nktx_NumberOfNonExclusiveRightsToGeneEditingTargetsLicensesReceived
Namespace Prefix: | nktx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments made under collaborative arrangement. + References No definition available. + Details
Name: | nktx_PaymentsMadeUnderCollaborativeArrangement
Namespace Prefix: | nktx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Potential future payments based on achievement of milestones. + References No definition available. + Details
Name: | nktx_PotentialFuturePaymentsBasedOnAchievementOfMilestones
Namespace Prefix: | nktx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Receivable under research cost sharing provision. + References No definition available. + Details
Name: | nktx_ReceivableUnderResearchCostSharingProvision
Namespace Prefix: | nktx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Reduction of research and development expense resulting from partial reimbursement. + References No definition available. + Details
Name: | nktx_ReductionOfResearchAndDevelopmentExpenseResultingFromPartialReimbursement
Namespace Prefix: | nktx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=nktx_ResearchCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=nktx_DevelopmentAndRegulatoryApprovalMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=nktx_NKCellProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=nktx_SpecifiedTaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |